Ashfield publishes a guide to Patient Support Programmes: Ten steps to success
pharmafile | August 12, 2016 | News story | Medical Communications, Research and Development, Sales and Marketing |
The priorities of Pharma and healthcare organisations are better aligned as a result of the industry’s increased efforts to put the patient at the heart of what they do. Pharma is investing in numerous patient-focused initiatives: from inviting patients in to hear their views to providing high quality, balanced patient education. Of all these things, Patient Support Programmes (PSPs) are perhaps making the biggest direct impact on patients’ health and quality of life.
There is no doubt that, when executed effectively, PSPs can have fantastic benefits for patients, prescribers, Pharma and everyone in-between. However, designing and delivering a successful PSP is complex, particularly when trying to deliver a consistent service across a number of healthcare systems. There are some key big questions e.g. How should the programme be designed? How should success be defined? What are the regulatory and governance considerations when dealing directly with patients and their data?
Ashfield’s clinical outsourcing expertise has helped pharma companies around the globe achieve improved patient outcomes. Using their 25 years’ experience, here is a guide to help answer key questions and plan a successful PSP.






